1 |
CSF3R
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | D03235
D03235
|
Filgrastim
| [34] 2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
2 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D01227
D01227
|
Bosentan
| [11] 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
3 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D07538
D07538
|
Bosentan
| [11] 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
4 |
EDNRB
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | D01227
D01227
|
Bosentan
| [11] 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
5 |
EDNRB
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | D07538
D07538
|
Bosentan
| [11] 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
6 |
EPOR
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | D03231
D03231
|
Erythropoietin
| [10] 2 2, 6, 13, 18, 22, 46, 47, 70, 95, 96 |
7 |
SERPINC1
| [1] Complement and coagulation cascades Complement and coagulation cascades | D07510
D07510
|
Heparin
| [12] 47 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 |
8 |
PTGIR
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation | D09994
D09994
|
Selexipag
| [6] 47 47, 51, 70, 84, 86, 88 |